---
title: View Crosstree Captials Recently Closed Health Sciences Transactions
description: Exlore Crosstree's most recently closed investment banking deals in the pharma services, diagnostics and tools, and healthcare technology industries.
---

# Our Deals

[ Connect with Us ](https://www.crosstreecapital.com/contact?hsLang=en)

###### Latest Deals

[![ROI Healthcare Solutions Acquired by Acuvance, a Portfolio Company of Trinity Hunt](https://www.crosstreecapital.com/hubfs/Tombstone_ROI_01_28_2026-1.png)

### ROI Healthcare Solutions Acquired by Acuvance, a Portfolio Company of Trinity Hunt

](https://www.crosstreecapital.com/deals/roi-healthcare-solutions-acquired-by-acuvance-a-portfolio-company-of-trinity-hunt?hsLang=en)

[![IPeople Acquired by RLDatix, a Portfolio Company of Five Arrows and TA Associates ](https://www.crosstreecapital.com/hubfs/Deal%20Insight%20Tombstone%20iPeople%20(3).png)

### IPeople Acquired by RLDatix, a Portfolio Company of Five Arrows and TA Associates

](https://www.crosstreecapital.com/deals/ipeople-acquired-by-rldatix-a-portfolio-company-of-five-arrows-and-ta-associates?hsLang=en)

[![Deep 6 AI Acquired by Tempus ](https://www.crosstreecapital.com/hubfs/Deep%206%20AITempus%20(315%20x%20315%20px).png)

### Deep 6 AI Acquired by Tempus 

](https://www.crosstreecapital.com/deals/deep-6-ai-acquired-by-tempus?hsLang=en)

[![Sengenics, a Portfolio Company of Summa Equity, Acquired by Standard BioTools](https://www.crosstreecapital.com/hubfs/Deal%20Insight%20Tombstone%20sengenics%20(2).png)

### Sengenics, a Portfolio Company of Summa Equity, Acquired by Standard BioTools

](https://www.crosstreecapital.com/deals/sengenics-a-portfolio-company-of-summa-equity-acquired-by-standard-biotools?hsLang=en)

[![Actigraph, a Portfolio Company of Archimed, Acquired Biofourmis’ Life Science Business](https://www.crosstreecapital.com/hubfs/Deal%20Insight%20Tombstone%20ActiGraph%20(1).png)

### Actigraph, a Portfolio Company of Archimed, Acquired Biofourmis’ Life Science Business

](https://www.crosstreecapital.com/deals/actigraph-a-portfolio-company-of-archimed-acquired-biofourmis-life-science-business?hsLang=en)

[![Bio-Techne Divested Assets of Its Subsidiary, Atlanta Biologicals, to GeminiBio](https://www.crosstreecapital.com/hubfs/Deal%20Insight%20Tombstone%20Biotechne.png)

### Bio-Techne Divested Assets of Its Subsidiary, Atlanta Biologicals, to GeminiBio

](https://www.crosstreecapital.com/deals/bio-techne-divested-assets-of-its-subsidiary-atlanta-biologicals-to-geminibio?hsLang=en)

[![Anju Software Acquired by Valsoft Corporation to Grow eClinical and Commercialization Capabilities](https://www.crosstreecapital.com/hubfs/Deal%20Insight%20Tombstone%20Anju%20+%20Valsoft.png)

### Anju Software Acquired by Valsoft Corporation to Grow eClinical and Commercialization Capabilities

](https://www.crosstreecapital.com/deals/anju-software-acquired-by-valsoft-corporation-to-grow-eclinical-and-commercialization-capabilities?hsLang=en)

[![Pinnacle Clinical Research Acquired The Cognitive and Research Center of New Jersey to Expand Clinical Trial Site Network](https://www.crosstreecapital.com/hubfs/Deal%20Insight%20Campaign%20LVCCRCNJ%20-%20Social.png)

### Pinnacle Clinical Research Acquired The Cognitive and Research Center of New Jersey to Expand Clinical Trial Site Network

](https://www.crosstreecapital.com/deals/pinnacle-clinical-research-a-portfolio-company-of-longuevue-capital-acquired-the-cognitive-and-research-center-of-new-jersey-to-expand-clinical-trial-site-network-to-expand-its-cns-trial-execution-capabilities?hsLang=en)

[![Pinnacle Clinical Research Acquires Kerwin Medical Center to Bolster Clinical Trial Site Network](https://www.crosstreecapital.com/hubfs/Deal%20Insight%20Campaign%20LVCKerwin%20-%20Social.png)

### Pinnacle Clinical Research Acquires Kerwin Medical Center to Bolster Clinical Trial Site Network

](https://www.crosstreecapital.com/deals/pinnacle-clinical-research-a-portfolio-company-of-longvue-capital-acquires-kerwin-medical-center-to-bolster-clinical-trial-site-network-and-trial-execution-capabilities?hsLang=en)

[![BBI Solutions, a Portfolio Company of Novo Holdings, Acquired IBEX Technologies Inc. to Bolster Recombinant Protein Offering](https://www.crosstreecapital.com/hubfs/Deal%20Insight%20Campaign%20Tombstone%20-%20BBIIBEX.png)

### BBI Solutions, a Portfolio Company of Novo Holdings, Acquired IBEX Technologies Inc. to Bolster Recombinant Protein Offering

](https://www.crosstreecapital.com/deals/bbi-solutions-a-portfolio-company-of-novo-holdings-acquired-ibex-technologies-inc?hsLang=en)

[![Myonex Acquired Creapharm's Clinical & Commercial Packaging and Bioservices Business Units to Expand Clinical Trial Supply Services and Gain of Foothold in Europe](https://www.crosstreecapital.com/hubfs/Deal%20Insight%20Campaign%20Myonex%20+%20Creapharm-%20Social%20V2.png)

### Myonex Acquired Creapharm's Clinical & Commercial Packaging and Bioservices Business Units to Expand Clinical Trial Supply Services and Gain of Foothold in Europe

](https://www.crosstreecapital.com/deals/myonex-acquired-creapharms-clinical-and-commercial-packaging-and-bioservices-business-units?hsLang=en)

[![Myonex Acquired SaveWay Compounding Pharmacy to Expand and Bolster its Clinical Trial Services Across the US](https://www.crosstreecapital.com/hubfs/Deal%20Insight%20Campaign%20Myonex%20+%20Creapharm-%20Social%20V2%20(1).png)

### Myonex Acquired SaveWay Compounding Pharmacy to Expand and Bolster its Clinical Trial Services Across the US

](https://www.crosstreecapital.com/deals/myonex-acquired-saveway-compounding-pharmacy?hsLang=en)

[![Calyx has divested its 'Enterprise Technology' Division to Ennov, to Enhance Ennov’s portfolio of eClinical and eRegulatory Software Solutions](https://www.crosstreecapital.com/hubfs/Deal%20Insight%20Campaign%20Tombstone%20-%20Calyx%20(Social%20Sized).V3-1.png)

### Calyx has divested its 'Enterprise Technology' Division to Ennov, to Enhance Ennov’s portfolio of eClinical and eRegulatory Software Solutions

](https://www.crosstreecapital.com/deals/calyx-has-divested-its-enterprise-technology-division-to-ennov-to-enhance-ennovs-portfolio-of-eclinical-and-eregulatory-software-solutions?hsLang=en)

[![physIQ Acquired by Prolaio to Enhance its Next-Gen Connected Heart Care Technology for Clinical Care and Research](https://www.crosstreecapital.com/hubfs/Deal%20Campaign%20Tombstone%20-%20PhysIQ%20(Social%20Sized)%20(1).png)

### physIQ Acquired by Prolaio to Enhance its Next-Gen Connected Heart Care Technology for Clinical Care and Research

](https://www.crosstreecapital.com/deals/physiq-acuired-by-prolaio?hsLang=en)

[![Continuum Clinical, a BC Worldwide company, Acquired by Spectrum Science, a Portfolio Company of Knox Lane, to Bolster Patient Engagement Capabilities](https://www.crosstreecapital.com/hubfs/Deal%20Insight%20Campaign%20Tombstone%20-%20Continuum%20Clinical%20(Social%20Sized).png)

### Continuum Clinical, a BC Worldwide company, Acquired by Spectrum Science, a Portfolio Company of Knox Lane, to Bolster Patient Engagement Capabilities

](https://www.crosstreecapital.com/deals/continuum-clinical-a-bc-worldwide-company-acquired-by-spectrum-science-a-portfolio-company-of-knox-lane-to-bolster-patient-engagement-capabilities?hsLang=en)

[![Yecuris Corporation Acquired by Janvier Group to Expand Preclinical Service Offering Internationally](https://www.crosstreecapital.com/hubfs/Deal%20Insight%20Campaign%20Tombstone%20-%20Yecuris%20(Social%20Sized)%20(NEW).png)

### Yecuris Corporation Acquired by Janvier Group to Expand Preclinical Service Offering Internationally

](https://www.crosstreecapital.com/deals/yecuris-acquired-by-janvier-group?hsLang=en)

[![Modular Devices, a Portfolio Company of O2 Investment Partners, Partners with Flow Clean Rooms and Supply to Bolster Existing Clean Room Manufacturing Capabilities and Expand Overall Offering](https://www.crosstreecapital.com/hubfs/2024-ModularDevices-Flow.png)

### Modular Devices, a Portfolio Company of O2 Investment Partners, Partners with Flow Clean Rooms and Supply to Bolster Existing Clean Room Manufacturing Capabilities and Expand Overall Offering

](https://www.crosstreecapital.com/deals/modular-devices-partners-with-flow-clean-room-and-supply?hsLang=en)

[![Alpha IRB Acquired by Sabai Global, a Portfolio Company of Thompson Street Capital, to Expand IRB Capabilities](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Deal-Insight-Campaign-Tombstone-Alpha-IRBSabai-Global-Social-Sized.png)

### Alpha IRB Acquired by Sabai Global, a Portfolio Company of Thompson Street Capital, to Expand IRB Capabilities

](https://www.crosstreecapital.com/deals/alpha-irb-acquired-by-sabai-global-a-portfolio-company-of-thompson-street-capital-to-expand-irb-capabilities?hsLang=en)

[![Versiti Acquired Pearl Pathways to Expand Clinical Trial Services Capabilities](https://www.crosstreecapital.com/hubfs/2024%20-%20Versiti%20-%20Pearl%20Pathways.png)

### Versiti Acquired Pearl Pathways to Expand Clinical Trial Services Capabilities

](https://www.crosstreecapital.com/deals/versiti-acquired-pearl-pathways-to-expand-clinical-trial-services-capabilities?hsLang=en)

[![VaxTRIALS Acquired by Emmes, a portfolio company of New Mountain Capital, to Expand Vaccine and Clinical Trial Site Capabilities](https://www.crosstreecapital.com/hubfs/2024%20-%20Vax%20Trials%20-%20Emmes.png)

### VaxTRIALS Acquired by Emmes, a portfolio company of New Mountain Capital, to Expand Vaccine and Clinical Trial Site Capabilities

](https://www.crosstreecapital.com/deals/vaxtrials-acuired-by-emmes?hsLang=en)

[View all deals](https://www.crosstreecapital.com/deals?hsLang=en)

## Sound strategies that yield superior outcomes

[ Consult Crosstree ](https://www.crosstreecapital.com/contact?hsLang=en)